13F

Stock

Aclaris Therapeutics, Inc.

ACRS · held by 2 managers

Reported value

$199.8K

Holders

2

+1 new · −0 exited

Holders’ est. mark

−$1.02M

Price effect on 1 books still in the name

Largest holder

$184.7K

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC175.9K$184.7K−$1.02MCut−$1.42M
Marex Group plc14.4K$15.1KNew

Positions as of Q4 2023. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.